Clinical pathological feature | Control (n = 30) | Tracer (n = 30) | Drug-load (n = 30) | Test value | P |
---|---|---|---|---|---|
Average age (year) | 45.4 ± 7.8 | 47.1 ± 8.3 | 48.4 ± 9.8 | 0.885* | 0.416 |
Tumor location | Â | Â | Â | 10.258# | 0.247 |
 Upper outer quadrant | 18 | 21 | 26 |  |  |
 Lower outer quadrant | 5 | 3 | 0 |  |  |
 Upper inner quadrant | 3 | 4 | 3 |  |  |
 Lower inner quadrant | 1 | 0 | 1 |  |  |
 Central area | 3 | 2 | 0 |  |  |
Clinical stage | Â | Â | Â | 2.018# | 0.732 |
 I | 8 | 8 | 6 |  |  |
 II | 18 | 15 | 16 |  |  |
 IIIA | 4 | 7 | 8 |  |  |
Pathological type | Â | Â | Â | 3.000# | 0.558 |
 Infiltrating ductal carcinoma | 29 | 29 | 29 |  |  |
 Mucinous carcinoma | 1 | 1 | 0 |  |  |
 Medullary carcinoma | 0 | 0 | 1 |  |  |
ER | Â | Â | Â | 1.348# | 0.510 |
 Positive | 19 | 20 | 23 |  |  |
 Negative | 11 | 10 | 7 |  |  |
PR | Â | Â | Â | 0.098# | 0.952 |
 Positive | 20 | 19 | 20 |  |  |
 Negative | 10 | 11 | 10 |  |  |
HER-2 | Â | Â | Â | 4.229# | 0.121 |
 Positive** | 3 | 8 | 3 |  |  |
 Negative## | 27 | 22 | 27 |  |  |
Surgical approach | Â | Â | Â | 4.488# | 0.344 |
 Modified radical mastectomy | 20 | 25 | 18 |  |  |
 Endoscopic subcutaneous mammary resection + axillary lymph nodes dissection + reconstruction with implants | 9 | 4 | 11 |  |  |
 Breast-conserving surgery + axillary lymph nodes dissection | 1 | 1 | 1 |  |  |